These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29674947)

  • 41. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychotic-Like Experiences and Concurrent Substance Use Among People Who Use New Psychoactive Substances.
    Ellilä V; Levola J; Denissoff A; Partanen M; Niemelä S
    Subst Use Misuse; 2023; 58(12):1606-1614. PubMed ID: 37482647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New psychoactive substances in emergency medicine].
    Marinowitz R; Strube J; Schaper A
    Nervenarzt; 2024 Jan; 95(1):28-34. PubMed ID: 38189941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE; Teesson M; Newton NC
    Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prodrugs of New Psychoactive Substances (NPS): A New Challenge.
    Elliott SP; Holdbrook T; Brandt SD
    J Forensic Sci; 2020 May; 65(3):913-920. PubMed ID: 31943218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Public attitudes toward depression and help-seeking: Impact of the OSPI-Europe depression awareness campaign in four European regions.
    Kohls E; Coppens E; Hug J; Wittevrongel E; Van Audenhove C; Koburger N; Arensman E; Székely A; Gusmão R; Hegerl U
    J Affect Disord; 2017 Aug; 217():252-259. PubMed ID: 28437762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New psychoactive substances: a review and updates.
    Shafi A; Berry AJ; Sumnall H; Wood DM; Tracy DK
    Ther Adv Psychopharmacol; 2020; 10():2045125320967197. PubMed ID: 33414905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head shops and new psychoactive substances: a public health perspective.
    Smyth BP
    Ir J Psychol Med; 2023 Mar; 40(1):89-96. PubMed ID: 33478611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Scale of Intoxications with New Psychoactive Substances over the Period 2014-2020-Characteristics of the Trends and Impacts of the COVID-19 Pandemic on the Example of Łódź Province, Poland.
    Garus-Pakowska A; Kolmaga A; Gaszyńska E; Ulrichs M
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Legal Approaches to New Psychoactive Substances: First Empirical Findings.
    van Amsterdam J; Burgess N; van den Brink W
    Eur Addict Res; 2023; 29(5):363-372. PubMed ID: 37557091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances.
    Ramos C; Guirguis A; Smeeton N; Zaman H; Felice AM; Bancroft S; Gittins R; Hawksworth G; Corkery JM; Schifano F
    Brain Sci; 2020 Mar; 10(3):. PubMed ID: 32131479
    [No Abstract]   [Full Text] [Related]  

  • 52. Consumption Patterns of Nightlife Attendees in Munich: A Latent-Class Analysis.
    Hannemann TV; Kraus L; Piontek D
    Subst Use Misuse; 2017 Sep; 52(11):1511-1521. PubMed ID: 28524714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior.
    Vreeker A; van der Burg BG; van Laar M; Brunt TM
    Addict Behav; 2017 Jul; 70():72-78. PubMed ID: 28214739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
    Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
    PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The importance of drug checking outside the context of nightlife in Slovenia.
    Sande M; Šabić S
    Harm Reduct J; 2018 Jan; 15(1):2. PubMed ID: 29329544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK.
    Gittins R; Guirguis A; Schifano F; Maidment I
    Brain Sci; 2018 Mar; 8(4):. PubMed ID: 29601550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatal Poisonings Associated with New Psychoactive Substances.
    Kronstrand R; Guerrieri D; Vikingsson S; Wohlfarth A; Gréen H
    Handb Exp Pharmacol; 2018; 252():495-541. PubMed ID: 30105471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?".
    Waldron J; Grabski M; Freeman TP; Mokrysz C; Hindocha C; Measham F; van Beek R; van der Pol P; Hauspie B; Dirkx N; Schrooten J; Elgán TH; Feltmann K; Benedetti E; Tomba GS; Fabi F; Molinaro S; Gripenberg J; van Havere T; van Laar M; Curran HV
    Int J Drug Policy; 2020 Aug; 82():102812. PubMed ID: 32554209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
    Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.